Clearside Biomedical
CLSD
CLSD
53 hedge funds and large institutions have $20.1M invested in Clearside Biomedical in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
46% less capital invested
Capital invested by funds: $37.4M → $20.1M (-$17.3M)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
64% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 25
Holders
53
Holding in Top 10
1
Calls
$305K
Puts
$372K
Top Buyers
| 1 | +$93.4K | |
| 2 | +$51K | |
| 3 | +$50.1K | |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$31.8K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$29.1K |
Top Sellers
| 1 | -$1.11M | |
| 2 | -$794K | |
| 3 | -$436K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$286K |
| 5 |
ACM
ACT Capital Management
Wayne,
Pennsylvania
|
-$251K |